Enhabit [EHAB] vs Astrana Health [ASTH] Detailed Stock Comparison

Enhabit Inc.

NYSE
Loading...

Astrana Health Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Enhabit Inc. wins in 8 metrics, Astrana Health Inc. wins in 11 metrics, with 0 ties. Astrana Health Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Enhabit Inc. Astrana Health Inc. Better
P/E Ratio (TTM) N/A 73.30 N/A
Price-to-Book Ratio 1.30 2.12 Enhabit Inc.
Debt-to-Equity Ratio 88.64 193.10 Enhabit Inc.
PEG Ratio 22.11 -0.41 Enhabit Inc.
EV/EBITDA 13.71 14.57 Enhabit Inc.
Profit Margin (TTM) -0.43% 0.71% Astrana Health Inc.
Operating Margin (TTM) 5.33% 1.85% Enhabit Inc.
EBITDA Margin (TTM) 5.33% 1.85% Enhabit Inc.
Return on Equity -0.47% 4.49% Astrana Health Inc.
Return on Assets (TTM) 3.33% 3.43% Astrana Health Inc.
Free Cash Flow (TTM) $65.80M $104.49M Astrana Health Inc.
1-Year Return 29.70% 49.98% Astrana Health Inc.
Price-to-Sales Ratio (TTM) 0.66 0.59 Astrana Health Inc.
Enterprise Value $1.18B $2.10B Astrana Health Inc.
EV/Revenue Ratio 1.12 0.66 Astrana Health Inc.
Gross Profit Margin (TTM) 48.71% 10.00% Enhabit Inc.
Revenue per Share (TTM) $21 $65 Astrana Health Inc.
Earnings per Share (Diluted) $-0.09 $0.46 Astrana Health Inc.
Beta (Stock Volatility) 1.08 0.77 Astrana Health Inc.
Short % of Float 2.74% 8.35% Enhabit Inc.

Enhabit Inc. vs Astrana Health Inc. Stock Performance Analysis

Loading Price Chart...

EHAB
ASTH

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Enhabit Inc.0.07%0.22%-1.00%22.23%70.58%51.82%
Astrana Health Inc.-0.62%-0.03%0.31%56.02%72.11%52.18%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Enhabit Inc.29.70%16.06%-44.80%-44.80%-44.80%-44.80%
Astrana Health Inc.49.98%24.10%-27.77%642.69%657.25%657.25%

Performance & Financial Health Analysis: Enhabit Inc. vs Astrana Health Inc.

MetricEHABASTH
Market Information
Market Cap i$703.84M$1.88B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i871,239497,178
90 Day Avg. Volume i1,167,950435,283
Last Close$13.80$38.38
52 Week Range$6.47 - $14.22$18.08 - $40.13
% from 52W High-2.95%-4.36%
All-Time High$25.25 (Jun 20, 2022)$133.23 (Nov 15, 2021)
% from All-Time High-45.35%-71.19%
Growth Metrics
Quarterly Revenue Growth0.05%0.43%
Quarterly Earnings Growth0.05%0.43%
Financial Health
Profit Margin (TTM) i0.00%0.01%
Operating Margin (TTM) i0.05%0.02%
Return on Equity (TTM) i0.00%0.04%
Debt to Equity (MRQ) i88.64193.10
Cash & Liquidity
Book Value per Share (MRQ)$10.53$15.94
Cash per Share (MRQ)$0.86$8.68
Operating Cash Flow (TTM) i$70.70M$114.60M
Levered Free Cash Flow (TTM) i$57.23M$227.95M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Enhabit Inc. vs Astrana Health Inc.

MetricEHAB (Apr 23, 2026)ASTH (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) iN/A73.30
Forward P/E i22.1110.50
PEG Ratio i22.11-0.41
Price to Sales (TTM) i0.660.59
Price to Book (MRQ) i1.302.12
Market Capitalization
Market Capitalization i$703.84M$1.88B
Enterprise Value i$1.18B$2.10B
Enterprise Value Metrics
Enterprise to Revenue i1.120.66
Enterprise to EBITDA i13.7114.57
Risk & Other Metrics
Beta i1.080.77
Book Value per Share (MRQ) i$10.53$15.94

Financial Statements Comparison: Enhabit Inc. vs Astrana Health Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEHAB (2025)ASTH (2025)
Revenue/Sales i1.06B3.18B
Cost of Goods Sold i540.20M2.84B
COGS % of Revenue i51.0%89.3%
Gross Profit i519.80M341.53M
Gross Margin i49.0%10.7%
Research & Development iN/AN/A
Operating Income (EBIT) i63.80M78.53M
Operating Margin i6.0%2.5%
EBITDA i105.60M135.35M
EBITDA Margin i10.0%4.3%
Pre-Tax Income i1.40M39.61M
Pre-Tax Income % of Revenue i0.1%1.2%
Income Tax i4.00M15.53M
Income Tax % of Revenue i0.4%0.5%
Net Income (Profit) i-2.60M24.08M
Profit Margin i-0.2%0.8%

Balance Sheet & Liquidity Metrics

MetricEHAB (2025)ASTH (2025)
Cash & Equivalents i43.60M429.47M
Total Current Assets i205.60M863.31M
Total Current Assets % of Revenue i19.4%27.1%
Total Current Liabilities i126.30M615.27M
Total Current Liabilities % of Revenue i11.9%19.3%
Long-Term Debt i465.10M1.02B
Long-Term Debt % of Revenue i43.9%32.1%
Total Shareholders Equity i564.10M558.33M
Retained Earnings i93.70M308.38M
Retained Earnings % of Revenue i8.8%9.7%
Property, Plant & Equipment i49.80M35.74M

Cash Flow Statement Comparison

MetricEHAB (2025)ASTH (2025)
Operating Cash Flow i40.80M109.88M
Operating Cash Flow % of Revenue i3.8%3.5%
Capital Expenditures i-4.90M-10.11M
Free Cash Flow i65.80M104.49M
FCF Margin i6.2%3.3%
Debt Repayment i-67.70M-495.29M
Common Stock Repurchase iN/A-15.43M

Short Interest & Institutional Ownership Analysis

MetricEHABASTH
Shares Short i1.35M2.68M
Short Ratio i0.896.86
Short % of Float i2.74%8.35%
Shares Outstanding i50.72M48.89M
Float Shares i44.11M44.36M
% Held by Insiders i3.61%20.32%
% Held by Institutions i88.49%52.52%
% Held by Public i7.90%27.16%

Dividend Analysis & Yield Comparison: Enhabit Inc. vs Astrana Health Inc.

MetricEHABASTH
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A